TEMIS launches Luxid® for Life Sciences

TEMIS, a leading provider of Text Analytics, today introduced its first industry-specific edition of Luxid®, its recently launched Information Intelligence solution, serving the global information needs of Life Sciences Corporations.

Luxid® for Life Sciences meets the specific requirements of pharmaceutical, biotechnology, and medical device organizations:

• It helps Life Sciences Corporations increase their research effort effectiveness. In order to support scientists from R&D team to explore the ever growing scientific literature, Luxid® for Life Sciences offers advanced features dedicated to the analysis of the relations between biological, medical and chemical entities. It provides a set of navigation and discovery tools enabling scientists to evaluate the “druggability” of a target or to profile a chemical compound.
• Luxid® for Life Sciences also assists legal departments with increasing their IP assets protection while prior art analysis is becoming increasingly difficult. Luxid® for Life Sciences gathers multiple patent sources, extracts and normalizes key metadata (assignees, patent series …) together with relevant entities (genes, diseases, chemical compounds …). It allows patent lawyers to speed up patent portfolios analysis to better evaluate freedom-to-operate opportunities around promising chemical compounds and also to detect early signals of possible patent infringement.
• Finally, Luxid® for Life Sciences helps Marketing and Safety departments monitor adverse event related risks. Luxid® for Life Sciences automates adverse event detection, through the extraction of relevant links between drugs, treatments and induced pathologies or symptoms. It even provides a workflow of escalation rules to comply with the latest pharmacovigilance regulatory obligations.

”We built our first industry-specific edition of Luxid® to meet the requirements of our most demanding Life Sciences customers.”, said Eric Brégand, CEO of TEMIS. “This corporate-wide single entry-point solution brings to the Scientist a comprehensive set of advanced knowledge discovery features to unlock the value from commercial, public and corporate data sources.”